Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Docetaxel and exisulind in previously treated non-small cell lung cancer (NSCLC) patients: a multicenter, phase II clinical trial.
Gene Drives: Biological Shield or Ecological Menace?
Science Policy and Funding Implications of the 2020 U.S. Election.
See All 3 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Gene Drives: Biological Shield or Ecological Menace?
Flotte TR. Gene Drives: Biological Shield or Ecological Menace? Hum Gene Ther. 2016 08; 27(8):561-2.
View in:
PubMed
subject areas
CRISPR-Cas Systems
Ecology
Environment
Gene Drive Technology
Genetic Therapy
Humans
Mutagenesis, Site-Directed
authors with profiles
Terence R Flotte MD